Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (251-260 of 292) with videos related to

Pageof 30
Sort By:
Acta Haematologica Polonica|January 1, 1980
[Prognostic value of peripheral blood T-lymphocyte count in lymphocytic leukemia]A Płuzańska, E Gawor, T Robak, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|December 2, 1991
[Results of treating acute myeloblastic leukemia in patients over 60 years of age]T Robak, E Krykowski, L Brodowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institutionP Smolewski, T Robak, E Krykowski, et al.
Lupus|March 12, 2009
Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosusE Robak, M Kierstan, B Cebula, et al.
European Journal of Haematology|March 2, 2002
Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndromeT Robak, H Urbańska-Ryś, B Strzelecka, et al.
Hematology (Amsterdam, Netherlands)|July 29, 2009
Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpuraT Robak, A Salama, L Kovaleva, et al.
Acta Haematologica Polonica|January 1, 1982
[Effect of splenectomy on hematological tolerance and the results of chemotherapy in Hodgkin's disease]T Robak, A Płuzańska, M Dmochowska, et al.
Mediators of Inflammation|October 2, 2001
Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activityE Robak, H Niewiadomska, T Robak, et al.
Vox Sanguinis|July 14, 2011
Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpuraJ W M van der Meer, R T van Beem, T Robak, et al.
Hematology (Amsterdam, Netherlands)|July 27, 2007
Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpuraL M Aledort, A Salama, L Kovaleva, et al.
Pageof 30

Showing results (251-260 of 292) with videos related to

Sort By:
Pageof 30
Acta Haematologica Polonica|January 1, 1980
[Prognostic value of peripheral blood T-lymphocyte count in lymphocytic leukemia]A Płuzańska, E Gawor, T Robak, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|December 2, 1991
[Results of treating acute myeloblastic leukemia in patients over 60 years of age]T Robak, E Krykowski, L Brodowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institutionP Smolewski, T Robak, E Krykowski, et al.
Lupus|March 12, 2009
Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosusE Robak, M Kierstan, B Cebula, et al.
European Journal of Haematology|March 2, 2002
Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndromeT Robak, H Urbańska-Ryś, B Strzelecka, et al.
Hematology (Amsterdam, Netherlands)|July 29, 2009
Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpuraT Robak, A Salama, L Kovaleva, et al.
Acta Haematologica Polonica|January 1, 1982
[Effect of splenectomy on hematological tolerance and the results of chemotherapy in Hodgkin's disease]T Robak, A Płuzańska, M Dmochowska, et al.
Mediators of Inflammation|October 2, 2001
Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activityE Robak, H Niewiadomska, T Robak, et al.
Vox Sanguinis|July 14, 2011
Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpuraJ W M van der Meer, R T van Beem, T Robak, et al.
Hematology (Amsterdam, Netherlands)|July 27, 2007
Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpuraL M Aledort, A Salama, L Kovaleva, et al.
Pageof 30